22
Participants
Start Date
October 15, 2018
Primary Completion Date
May 15, 2024
Study Completion Date
June 8, 2024
Control (Norepinephrine)
This intervention is aimed at assessing the vascular responsiveness to norepinephrine, an alpha 1-agonist, in white and black men and women across a series of ascending dose concentrations.
Norepinephrine + Ascorbic Acid
This intervention is meant to globally assess the impact of oxidative stress on vasoconstrictor responses by scavenging numerous oxidative molecules.
Norepinephrine + L-NAME
This intervention is meant to assess the impact of endothelium-derived nitric oxide on vasoconstrictor responses by inhibiting production of this source of nitric oxide.
Norepinephrine + L-NAME + Ascorbic Acid
This intervention is meant to assess the combined impact of scavenging oxidative stress and inhibiting endothelium-derived nitric oxide on vasoconstrictor responses.
Science and Engineering Research and Innovation Building, Arlington
The University of Texas at Arlington
OTHER